(0.80%) 5 277.51 points
(1.51%) 38 686 points
(-0.01%) 16 735 points
(-0.94%) $77.18
(0.35%) $2.58
(-0.79%) $2 347.70
(-3.10%) $30.56
(0.63%) $1 044.50
(-0.17%) $0.921
(-0.49%) $10.49
(-0.05%) $0.785
(0.15%) $90.40
-3.57% $ 2.97
Live Chart Being Loaded With Signals
Century Therapeutics, Inc., a biotechnology company, develops transformative allogeneic cell therapies for the treatment of solid tumor and hematological malignancies...
Stats | |
---|---|
Volumen de hoy | 86 539.00 |
Volumen promedio | 123 677 |
Capitalización de mercado | 247.03M |
EPS | $0 ( 2024-05-09 ) |
Próxima fecha de ganancias | ( $-0.500 ) 2024-08-14 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -1.340 |
ATR14 | $0.0180 (0.60%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-05-20 | Russotti Gregory | Sell | 5 000 | Common Stock |
2024-05-06 | Russotti Gregory | Sell | 5 000 | Common Stock |
2024-05-03 | Carr Douglas | Sell | 257 | Common Stock |
2024-05-03 | Farid Adrienne | Sell | 913 | Common Stock |
2024-04-22 | Russotti Gregory | Sell | 5 000 | Common Stock |
INSIDER POWER |
---|
70.75 |
Last 96 transactions |
Buy: 10 700 785 | Sell: 3 082 886 |
Volumen Correlación
Century Therapeutics, Correlación
10 Correlaciones Más Positivas |
---|
10 Correlaciones Más Negativas |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Century Therapeutics, Correlación - Moneda/Commodity
Century Therapeutics, Finanzas
Annual | 2023 |
Ingresos: | $2.24M |
Beneficio Bruto: | $-10.81M (-483.62 %) |
EPS: | $-2.30 |
FY | 2023 |
Ingresos: | $2.24M |
Beneficio Bruto: | $-10.81M (-483.62 %) |
EPS: | $-2.30 |
FY | 2022 |
Ingresos: | $5.20M |
Beneficio Bruto: | $-4.87M (-93.71 %) |
EPS: | $-2.27 |
FY | 2021 |
Ingresos: | $0.00 |
Beneficio Bruto: | $0.00 (0.00 %) |
EPS: | $-1.759 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Century Therapeutics,
Century Therapeutics, Inc., a biotechnology company, develops transformative allogeneic cell therapies for the treatment of solid tumor and hematological malignancies. The company\'s lead product candidate is CNTY-101, an allogeneic, induced pluripotent stem cells (iPSCs)-derived chimeric antigen receptors (CAR)-iNK cell therapy targeting CD19 for relapsed, refractory B-cell lymphoma. It is also developing CNTY-103, a CAR-iNK candidate targeting CD133 + EGFR for recurrent glioblastoma; CNTY-102, a CAR-iT targeting CD19 + CD79b for relapsed, refractory B-cell lymphoma and other B-cell malignancies; CNTY-104, a CAR-iT or CAR-iNK multi-specific candidate for acute myeloid leukemia; and CNTY-106, a CAR-iNK or CAR-iT multi-specific candidate for multiple myeloma. Century Therapeutics, Inc. was founded in 2018 and is headquartered in Philadelphia, Pennsylvania.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico